Literature DB >> 19375079

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.

M T Cooney1, A Dudina, D De Bacquer, L Wilhelmsen, S Sans, A Menotti, G De Backer, P Jousilahti, U Keil, T Thomsen, P Whincup, I M Graham.   

Abstract

OBJECTIVE: We aimed to clarify some previous inconsistencies regarding the role of high density lipoprotein cholesterol (HDL-C) as a CVD protective factor.
METHODS: The SCORE dataset contained data on HDL-C for 104,961 individuals (45% women) without pre-existing coronary heart disease (CHD). These were from 7 pooled European prospective studies. The effect of HDL-C, both in quintiles and as a continuous variable, on risk of CVD and CHD mortality was examined, using Cox proportional hazards model, adjusted for age, total cholesterol, systolic blood pressure, smoking, diabetes and body mass index and stratified by gender, age group, country and category of SCORE CVD risk.
RESULTS: A strong, graded, independent, inverse relationship between HDL-C and both CVD and CHD mortality was demonstrated. Adjusted hazard ratios per 0.5mmol/l increase in HDL-C were 0.60 (0.51, 0.69) and 0.76 (0.70, 0.83) in women and men, respectively for the CVD mortality endpoint. The corresponding hazard ratios were 0.53 (0.42, 0.68) and 0.79 (0.64, 0.98) in elderly women and men, respectively. The relationship was significant in all SCORE CVD risk strata and age groups.
CONCLUSIONS: This multivariable analysis, the largest of its kind to date, has confirmed the inverse, independent, strong and graded relationship between HDL-C and both CVD and CHD mortality. We have clarified previous suggestions that the relationship is stronger in women and that it applies in all age groups. This is the first prospective study to demonstrate the independent relationship specifically in healthy elderly women and to show that the relationship holds at all levels of total CVD risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375079     DOI: 10.1016/j.atherosclerosis.2009.02.041

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  59 in total

Review 1.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

2.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

Review 3.  Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Jean C McSweeney; Anne G Rosenfeld; Willie M Abel; Lynne T Braun; Lora E Burke; Stacie L Daugherty; Gerald F Fletcher; Martha Gulati; Laxmi S Mehta; Christina Pettey; Jane F Reckelhoff
Journal:  Circulation       Date:  2016-02-29       Impact factor: 29.690

4.  Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors.

Authors:  Imrich Blasko; Georg Kemmler; Susanne Jungwirth; Ildiko Wichart; Silvia Weissgram; Kurt Jellinger; Karl Heinz Tragl; Peter Fischer
Journal:  J Neural Transm (Vienna)       Date:  2011-02-23       Impact factor: 3.575

Review 5.  Recognizing and improving health care disparities in the prevention of cardiovascular disease in women.

Authors:  Jennifer L Jarvie; Joanne M Foody
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

6.  Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study.

Authors:  Mohsen Janghorbani; Masoud Amini; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2016-08-10

Review 7.  The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease.

Authors:  Philippe Meyer; Anil Nigam; Michel Marcil; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2009-09       Impact factor: 5.113

8.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

9.  Endurance training enhances LXRα gene expression in Wistar male rats.

Authors:  Fatemeh Kazeminasab; Mohammad Marandi; Kamran Ghaedi; Fahimeh Esfarjani; Jamal Moshtaghian
Journal:  Eur J Appl Physiol       Date:  2013-05-15       Impact factor: 3.078

Review 10.  Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Authors:  Ian Graham; Marie-Therese Cooney; David Bradley; Alexandra Dudina; Zeljko Reiner
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.